The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
125075042 12507504 2 F 20160725 20160629 20160729 EXP BE-ROCHE-1782796 ROCHE 0.00 F Y 0.00000 20160729 MD BE BE

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
125075042 12507504 1 PS LUCENTIS RANIBIZUMAB 1 Other UNK, IN THE LEFT EYE N 125156 SOLUTION FOR INJECTION
125075042 12507504 2 SS LUCENTIS RANIBIZUMAB 1 Other UNK, IN THE LEFT EYE N 125156 SOLUTION FOR INJECTION
125075042 12507504 3 SS LUCENTIS RANIBIZUMAB 1 Other UNK, IN THE LEFT EYE N 125156 SOLUTION FOR INJECTION
125075042 12507504 4 SS LUCENTIS RANIBIZUMAB 1 Other UNK, IN THE LEFT EYE N 125156 SOLUTION FOR INJECTION
125075042 12507504 5 SS AVASTIN BEVACIZUMAB 1 Unknown UNK, OS N 125085 SOLUTION FOR INFUSION
125075042 12507504 6 SS AVASTIN BEVACIZUMAB 1 Unknown UNK, OS N 125085
125075042 12507504 7 SS AVASTIN BEVACIZUMAB 1 Unknown UNK, OS N 125085
125075042 12507504 8 SS AVASTIN BEVACIZUMAB 1 Unknown UNK, OS N 125085
125075042 12507504 9 SS AVASTIN BEVACIZUMAB 1 Unknown UNK, OS N 125085
125075042 12507504 10 SS AVASTIN BEVACIZUMAB 1 Unknown UNK, OS N 125085
125075042 12507504 11 SS AVASTIN BEVACIZUMAB 1 Unknown UNK, OS N 125085
125075042 12507504 12 SS AVASTIN BEVACIZUMAB 1 Unknown UNK, OS N 125085
125075042 12507504 13 SS AVASTIN BEVACIZUMAB 1 Unknown UNK, OS N 125085
125075042 12507504 14 SS AVASTIN BEVACIZUMAB 1 Unknown UNK, OS N 125085
125075042 12507504 15 SS AVASTIN BEVACIZUMAB 1 Unknown UNK, OS N 125085
125075042 12507504 16 SS AVASTIN BEVACIZUMAB 1 Unknown UNK, OS N 125085
125075042 12507504 17 SS AVASTIN BEVACIZUMAB 1 Unknown UNK, OS N 125085

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
125075042 12507504 1 Choroidal neovascularisation
125075042 12507504 5 Choroidal neovascularisation

Outcome of event

Event ID CASEID OUTC COD
125075042 12507504 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
125075042 12507504 Choroidal neovascularisation
125075042 12507504 Haemorrhage
125075042 12507504 Macular oedema
125075042 12507504 Off label use
125075042 12507504 Retinal degeneration
125075042 12507504 Visual acuity reduced

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
125075042 12507504 1 20100127 0
125075042 12507504 2 20100304 0
125075042 12507504 3 20100401 0
125075042 12507504 4 20100715 20100715 0
125075042 12507504 5 20101021 0
125075042 12507504 6 20101202 0
125075042 12507504 7 20110527 0
125075042 12507504 8 20110804 0
125075042 12507504 9 20111006 0
125075042 12507504 10 20130214 0
125075042 12507504 11 20130409 0
125075042 12507504 12 20130924 0
125075042 12507504 13 20131114 0
125075042 12507504 14 20140102 0
125075042 12507504 15 20140206 0
125075042 12507504 16 20140313 0
125075042 12507504 17 20140515 0